Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04839601 · ClinicalTrials.gov registry record · NA
RNS System RESPONSE Study
A NA study, sponsored by NeuroPace.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04839601 is a NA study that was terminated before completion, run by NeuroPace. The registered enrollment target is 9 participants.
The verdict
NCT04839601, a NA study, was terminated before completion, sponsored by NeuroPace.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
To demonstrate that the RNS System is safe and effective as an adjunctive therapy in individuals age 12 through 17 years with medically refractory partial onset epilepsy.
Interventions
- DEVICE RNS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-10-27 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04839601
The ClinicalTrials.gov registry entry for NCT04839601 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NeuroPace, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RNS System is the first listed.
NCT04839601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04839601 about?
NCT04839601 is a clinical study titled "RNS System RESPONSE Study". To demonstrate that the RNS System is safe and effective as an adjunctive therapy in individuals age 12 through 17 years with medically refractory partial onset epilepsy.
What is the current status of trial NCT04839601?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2021-10-27. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT04839601?
The interventions under investigation include: RNS System (DEVICE).
Who is sponsoring clinical trial NCT04839601?
This trial is sponsored by NeuroPace, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.